HOME › DRUGS › SAXAGLIPTIN HYDROCHLORIDE
ACTIVE SUBSTANCE / INN

SAXAGLIPTIN HYDROCHLORIDE

Brand name(s): KOMBIGLYZE XR, QTERNMET XR, QTERN, SAXAGLIPTIN, SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE, ONGLYZA
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA200678
ANDA205980
ACTIVE SUBSTANCE
Saxagliptin Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
ASTRAZENECA AB, SUN PHARM, AMNEAL
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SAXAGLIPTINANDA205980MYLANPrescription
QTERNMET XRNDA210874ASTRAZENECA ABDiscontinued
ONGLYZANDA022350ASTRAZENECA ABDiscontinued
QTERNNDA209091ASTRAZENECA ABDiscontinued
KOMBIGLYZE XRNDA200678ASTRAZENECA ABDiscontinued
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA205981MYLANPrescription
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA206081SUN PHARMDiscontinued
SAXAGLIPTINANDA205941AMNEALDiscontinued

FULL INTELLIGENCE ON SAXAGLIPTIN HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →